文献速递肿瘤 PET/CT核素与放射性配体治疗

机器学习识别多参数功能性PET/MR成像聚类以预测临床前头颈癌模型的放射抵抗

Machine learning identifies multi-parametric functional PET/MR imaging cluster to predict radiation resistance in preclinical head and neck cancer models.
PubMed 文献 · Eur J Nucl Med Mol Imaging · 2023-05-06

本研究将八种人头颈癌异种移植模型植入68只免疫缺陷小鼠,在分次放疗前后行动态[18F]-氟米索硝唑缺氧PET、弥散加权及动态增强MRI,采用主成分分析和表观弥散系数在体素水平分析,训练机器学习模型识别高危亚体积聚类。42只动物有完整5D数据,基线3D成像空间(ADC和两个FMISO主成分)模型分层潜力最高,ADC和FMISO聚类与放射抵抗相关,作者认为这些聚类是未来功能影像引导放疗剂量雕刻的潜在靶点,需临床验证。

要点

  • 基线3D成像空间(ADC和两个FMISO主成分)的模型对放射敏感性的分层潜力最高。
  • 在1D成像空间中,仅ADC聚类显示显著分层潜力。
  • 经典特征中仅ADCvalley与放射抵抗显著相关,放疗2周后FMISO_c1与放射抵抗显著相关。

核心结论

  • 临床前研究描述了一种定量成像指标,提示头颈癌的放射抵抗亚体积可能通过联合PET/MRI的ADC和FMISO聚类检测,这些聚类是未来功能影像引导放疗剂量雕刻方法的潜在靶点,需临床验证。

研究设计与样本

  • 临床前研究,将八种人头颈癌异种移植模型植入68只免疫缺陷小鼠。
  • 在分次放疗(10次×2 Gy)前后行动态[18F]-氟米索硝唑缺氧PET、弥散加权和动态增强MRI。
  • 成像数据在体素水平采用主成分分析动态数据和表观弥散系数分析弥散加权MRI。
  • 训练数据和假设驱动的机器学习模型,从放疗前后多维(1-5D)临床前成像数据中识别高危亚体积聚类。
  • 采用Cohen's d评分评估各1D至5D模型对放射敏感性的分层潜力,并与经典特征比较。

主要发现

  • 42只动物有完整5D成像数据。
  • 基线高危亚体积识别最终临床前模型在3D成像空间(基于ADC和两个FMISO主成分)分层潜力最高([公式:见原文])。
  • 在1D成像空间中,仅ADC聚类显示显著分层潜力([公式:见原文])。
  • 所有经典特征中,仅ADCvalley与放射抵抗显著相关([公式:见原文])。
  • 放疗2周后,FMISO_c1与放射抵抗显著相关([公式:见原文])。

关键数值与推荐

  • 分层潜力以Cohen's d评分评估,原文未报告具体评分值。
  • 经典特征包括平均/峰值/最大标准化摄取值(SUVmean/peak/max)和肿瘤-肌肉比值(TMRpeak/max)以及最小/谷值/最大/平均ADC。
  • 原文未报告显著性阈值或P值。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 作者指出需临床验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Tumor hypoxia and other microenvironmental factors are key determinants of treatment resistance. Hypoxia positron emission tomography (PET) and functional magnetic resonance imaging (MRI) are established prognostic imaging modalities to identify radiation resistance in head-and-neck cancer (HNC). The aim of this preclinical study was to develop a multi-parametric imaging parameter specifically for focal radiotherapy (RT) dose escalation using HNC xenografts of different radiation sensitivities. METHODS: A total of eight human HNC xenograft models were implanted into 68 immunodeficient mice. Combined PET/MRI using dynamic [18F]-fluoromisonidazole (FMISO) hypoxia PET, diffusion-weighted (DW), and dynamic contrast-enhanced MRI was carried out before and after fractionated RT (10 × 2 Gy). Imaging data were analyzed on voxel-basis using principal component (PC) analysis for dynamic data and apparent diffusion coefficients (ADCs) for DW-MRI. A data- and hypothesis-driven machine learning model was trained to identify clusters of high-risk subvolumes (HRSs) from multi-dimensional (1-5D) pre-clinical imaging data before and after RT. The stratification potential of each 1D to 5D model with respect to radiation sensitivity was evaluated using Cohen's d-score and compared to classical features such as mean/peak/maximum standardized uptake values (SUVmean/peak/max) and tumor-to-muscle-ratios (TMRpeak/max) as well as minimum/valley/maximum/mean ADC. RESULTS: Complete 5D imaging data were available for 42 animals. The final preclinical model for HRS identification at baseline yielding the highest stratification potential was defined in 3D imaging space based on ADC and two FMISO PCs ([Formula: see text]). In 1D imaging space, only clusters of ADC revealed significant stratification potential ([Formula: see text]). Among all classical features, only ADCvalley showed significant correlation to radiation resistance ([Formula: see text]). After 2 weeks of RT, FMISO_c1 showed significant correlation to radiation resistance ([Formula: see text]). CONCLUSION: A quantitative imaging metric was described in a preclinical study indicating that radiation-resistant subvolumes in HNC may be detected by clusters of ADC and FMISO using combined PET/MRI which are potential targets for future functional image-guided RT dose-painting approaches and require clinical validation.

来源:Eur J Nucl Med Mol Imaging,查看原文。版权归原作者所有。

引用

  1. Boeke S, Winter RM, Leibfarth S, et al. Machine learning identifies multi-parametric functional PET/MR imaging cluster to predict radiation resistance in preclinical head and neck cancer models. Eur J Nucl Med Mol Imaging. 2023. PMID: 37148296. doi:10.1007/s00259-023-06254-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。